ABC | Volume 110, Nº2, February 2018

Original Article Bouabdallaoui et al Heart Transplantation for PPCM Arq Bras Cardiol. 2018; 110(2):181-187 Table 3 – Transplant-related complications and causes of Death Transplant-related complications PPCM group (n = 14) Control group (n = 28) p Rejection: Treated rejections < 1-year post transplant 50% (n = 7) 50% (n = 14) p = 0.5 Treated rejections > 1-year post transplant 71% (n = 10) 50% (n = 14) p = 0.6 Infection rate 35.7% (n = 5) 64.3% (n = 18) p = 0.07 CAV 50% (n = 7) 35.7% (n = 10) p = 0.4 Death: Early all-cause mortality (< 1 year) 7% (n = 1) 21.4% (n = 6) p = 0.06 Rejection n = 0 n = 1 Infection n = 0 n = 2 CAV n = 0 n = 0 Hemorrhagic complications n = 1 n = 2 Thromboembolic complications n = 0 n = 1 Death: Late all-cause mortality (> 1 year) 21.4% (n = 3) 46.4% (n = 13) p = 0.07 Rejection n = 1 n = 2 Infection n = 0 n = 3 CAV n = 1 n = 4 Hemorrhagic complications n = 1 n = 2 Thromboembolic complications n = 0 n = 1 Neoplasia n = 0 n = 1 Unknown n = 1 n = 0 CAV: Cardiac Allograft Vasculopathy (Comparisons between groups for continuous variables were performed using the Student t-test or the Mann Whitney U test as appropriate). Figure 1 – Long-term survival after heart transplantation, PPCM group (PPCM (+)) and control patients (PPCM (-)). PPCM: peripartum cardiomyopathy. 100 80 60 40 20 0 0 3 6 9 12 15 Number at risk Group: PPCM (+) Group: PPCM (–) 14 10 8 5 3 3 28 18 13 9 5 2 P = 0.03 PPCM (+) PPCM (–) Follow up (years) Survival (%) 184